← Back to Search

Other

Cook Medical EMR Gel for Stomach Cancer

Phase 3
Waitlist Available
Led By Danny Sherwinter, MD
Research Sponsored by Antonios Likourezos
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial is testing a special gel to see how its thickness affects the ease of a specific type of surgery. The gel is injected under the tissue to lift it, making the surgery easier. The study uses tissues from routine surgeries to simulate real conditions.

Eligible Conditions
  • Stomach Cancer
  • Colon Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lift Efficacy
Secondary study objectives
Dissection Adequacy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cook medical EMR GelExperimental Treatment1 Intervention
Prospective study involving excised human stomachs and colon harvested from sleeve gastrectomies and colectomies performed for benign or malignant disease. Different Cook submucosal injections of varying viscosities will be injected into different areas of the excised stomachs or colons. Data collected will involve lifting characteristics and dissection adequacy of the varying viscosities of gel.

Find a Location

Who is running the clinical trial?

Antonios LikourezosLead Sponsor
39 Previous Clinical Trials
8,454 Total Patients Enrolled
Maimonides Medical CenterLead Sponsor
71 Previous Clinical Trials
15,510 Total Patients Enrolled
Danny Sherwinter, MDPrincipal InvestigatorMaimonides Medical Center
3 Previous Clinical Trials
117 Total Patients Enrolled
~0 spots leftby Nov 2025